MORGAN STANLEY - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$1,306,319,218
-10.4%
48,132,615
+1.5%
0.13%
-7.6%
Q2 2023$1,457,994,028
-14.5%
47,429,861
+0.2%
0.14%
-21.3%
Q1 2023$1,706,037,085
-12.3%
47,350,458
-3.8%
0.18%
-17.2%
Q4 2022$1,946,203,263
-3.5%
49,246,032
-1.9%
0.22%
-19.6%
Q3 2022$2,016,482,000
-6.9%
50,186,161
-2.6%
0.28%
-2.1%
Q2 2022$2,166,876,000
+3.9%
51,543,171
-3.7%
0.28%0.0%
Q1 2022$2,085,987,000
-6.9%
53,541,788
-4.8%
0.28%
+1.4%
Q4 2021$2,240,794,000
+8.2%
56,230,690
-1.9%
0.28%
-0.7%
Q3 2021$2,071,013,000
-0.5%
57,305,311
+12.8%
0.28%
+1.5%
Q2 2021$2,082,049,000
-0.8%
50,794,041
+5.6%
0.28%
-10.7%
Q1 2021$2,098,917,000
+76.2%
48,118,242
+102.2%
0.31%
+67.4%
Q4 2020$1,191,094,000
+202.3%
23,798,081
+154.1%
0.18%
+142.1%
Q3 2020$394,053,000
+30.8%
9,366,618
+50.9%
0.08%
+13.4%
Q2 2020$301,261,0006,205,1860.07%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$294,957,00088.74%
Vantage Consulting Group Inc 8,705,551$379,735,00076.23%
Memorial Sloan Kettering Cancer Center 2,680,644$116,930,00072.07%
HARVARD MANAGEMENT CO INC 10,714,284$467,357,00026.11%
ROBERT WOOD JOHNSON FOUNDATION 970,151$4,231,798,00021.59%
Brown University 381,759$16,652,00011.44%
Overbrook Management Corp 771,155$33,638,0007.48%
SpiderRock Advisors, LLC 778,800$34,236,0004.79%
Renaissance Capital LLC 452,948$19,758,0002.93%
Lagoda Investment Management, L.P. 104,835$4,573,0002.28%
View complete list of ROYALTY PHARMA PLC shareholders